COSCIENS Biopharma Inc T.AEZS

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:AEZS - Post by User

COSCIENS Biopharma Inc > Did Gilles buy AEZS at the bottom of the biotech market?

<< Previous

Bullboard Posts

Next >>

Post by prophetoffactzon Jun 04, 2024 4:38pm

87 Views

Post# 36071954

Did Gilles buy AEZS at the bottom of the biotech market?

@EconguyRosie

The JOLTS data show that the openings rate, the hiring rate, and the quit rate are all lower today than they were just before the pandemic hit – a time when the entire Treasury curve out to the 10-year note was trading comfortably below a 2% yield. I’m not budging an inch from my bond-bullish stance.

<< Previous

Bullboard Posts

Next >>

How to navigate the ups and downs of investing in AI